SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-120349
Filing Date
2022-04-26
Accepted
2022-04-26 16:38:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d344184ddefa14a.htm DEFA14A 26893
2 GRAPHIC g344184g91t62.jpg GRAPHIC 37106
3 GRAPHIC g344184gra003a.jpg GRAPHIC 11748
4 GRAPHIC g344184gra004.jpg GRAPHIC 908
  Complete submission text file 0001193125-22-120349.txt   96840
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36152 | Film No.: 22854907
SIC: 2836 Biological Products, (No Diagnostic Substances)